Keyphrases
Attenuation
5%
Cancer Cells
5%
Cancer Stem Cells
24%
Cancer Stemness
13%
Catenin
15%
CD133
15%
Cell Survival
5%
Chemoresistance
7%
Chemotherapy
5%
Drug Resistance
13%
Epithelial-mesenchymal Transition
5%
FTY720
13%
Hepatocarcinogenesis
7%
Hepatocellular Carcinoma
100%
Hepatocellular Carcinoma Cells
25%
Hepatocellular Carcinoma Metastasis
10%
Hepatocellular Carcinoma Patients
6%
Hepatocellular Carcinoma Progression
6%
Hepatoma Cells
5%
Id-1
8%
In Cancer
7%
Liver
6%
Liver Cancer
10%
Liver Cancer Stem Cells
23%
Liver Graft Injury
5%
Metastasis
17%
Metastatic Hepatocellular Carcinoma
5%
Molecular Mechanism
5%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
5%
Overexpression
15%
Prostate Cancer Cells
9%
Reperfusion
6%
Self-renewal
15%
Signaling Cascades
7%
Signaling Pathway
6%
Small-for-size
8%
Sorafenib
9%
Sorafenib Resistance
7%
Stem Cells
6%
Stemness
8%
Therapeutic Target
8%
Tumor
12%
Tumor Growth
16%
Tumor Metastasis
6%
Tumor-initiating Cells
11%
Medicine and Dentistry
Cancer
6%
Cancer Cell
6%
Cancer Stem Cell
32%
Carcinoma Cell
5%
Cell Signaling Pathway
5%
down Regulation
7%
Drug Resistance
10%
Endothelin 1
5%
Fingolimod
8%
Gene Expression
6%
Graft Survival
6%
Hepatocellular Carcinoma
67%
Liver Cancer
12%
Liver Carcinogenesis
5%
Liver Graft
11%
Liver Transplantation
10%
Liver Tumor
6%
Malignant Neoplasm
8%
Metastatic Carcinoma
27%
Neoplasm
12%
Prostate Cancer
8%
Sorafenib
7%
Tumor Progression
13%
Upregulation
9%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
5%
Cancer Cell
13%
Cancer Stem Cell
40%
Carcinogenesis
8%
Catenin
15%
CD133
13%
Cell Proliferation
6%
down Regulation
7%
Drive
5%
Drug Resistance
15%
Messenger RNA
5%
Programmed Cell Death
6%
Reperfusion
6%
Sorafenib
7%
Stem Cell Marker
5%
Tumor Progression
10%
Upregulation
10%